‘Nothing Unexpected’ In Third Failed Application For OTC Sildenafil In Germany

“Overall, no unexpected/new data or findings” were presented to Germany's Expert Committee for Prescription in the most recent Rx-to-OTC switch application for sildenafil (25mg and 50mg), according to medicines regulator BfArM, resulting in a third rejection in three years.

Rejected
Viatris' application to switch sildenafil to OTC status in Germany rejected for third time

More from Europe

More from Rx-to-OTC Switch